Anthera Pharmaceuticals- It can only be long

152 1 1
Everything says this is bullish to me, at least for the short term.

Fundamentally, Anthera have today announced the successful completion of an interim analysis of its Phase 3 trial (CHABLIS-SC1) of blisibimod in patients with Systemic Lupus Erythematosus and that the study should continue to completion as planned. This is a critical milestone for the company.

In terms of technical analysis , The only problem is the historical resistance zone I've discovered (The black line going across the chart.)
I'm looking to take profits very quickly in case of a turn around and have a stop loss in place.

Break above the 200 EMA and the Slow curve pattern as well as the trendline resistance tells me this is a home run.

I took an aggressive entry and got filled at 3.29 so I've already hit a complete home run here.

Good luck traders.

Trading Course & Signals Subscription Queries:

- Email:
- Telegram: @tomprotrader

Public Telegram channel:

Please ignore all indicators except the Stochastic here. The other indicators were left on herer by accident. :)
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out